Medios AG
ILM1
Rank in Stocks
#14385
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical... Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.
Share Price
$12.79
Last synced: 2026-11-09
Market Cap
$326.32M
Change (1 day)
1.20%
Change (1 year)
-25.82%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Medios AG (ILM1)
Category
Healthcare
Operating Margin for Medios AG (ILM1)
Operating Margin as of November 2026 TTM: 1.92%
According to Medios AG's latest financial reports, its current operating margin (TTM) is 1.92%. At the end of 2025 the company had an operating margin of 2.01%.
Operating Margin history for Medios AG from 2009 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 1.92% | -4.48% |
| 2025 | 2.01% | 19.64% |
| 2024 | 1.68% | -4.55% |
| 2023 | 1.76% | -2.22% |
| 2022 | 1.80% | 60.71% |
| 2021 | 1.12% | -26.32% |
| 2020 | 1.52% | -45.32% |
| 2019 | 2.78% | 23.01% |
| 2018 | 2.26% | -15.67% |
| 2017 | 2.68% | -532.26% |
| 2016 | -0.62% | -100.00% |
| 2015 | -118,257.76% | 15,902.62% |
| 2014 | -738.99% | -98.54% |
| 2013 | -50,645.58% | 8,654.03% |
| 2012 | -578.54% | -26,760.83% |
| 2011 | 2.17% | -99.08% |
| 2010 | 234.95% | 0.00% |
| 2009 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 1.62% | -99.16% |
US
|
|
| 1.30% | -99.32% |
US
|
|
| 1.03% | -99.46% |
US
|
|
| 0.91% | -99.53% |
US
|
|
| 9.21% | -95.20% |
AU
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Medios AG's operating margin
What is Medios AG's operating margin?
Medios AG's operating margin is 1.92%, as of Nov 2026.
What was Medios AG's operating margin in 2025?
In 2025, Medios AG's operating margin was 2.01%, compared with 1.68% in 2024.
How has Medios AG's operating margin changed since 2020?
From 2020 to 2025, Medios AG's operating margin was highest in 2025 (2.01%) and lowest in 2021 (1.12%).
How does Medios AG's operating margin compare with similar companies?
Medios AG's operating margin (1.92%) is higher than that of 4 of the 5 similar companies listed above. The highest among them is Sigma Healthcare Limited, with 9.21%.